Tuberculous episcleritis
ICD-10 A18.51 is a billable code used to indicate a diagnosis of tuberculous episcleritis.
Tuberculous episcleritis is an inflammatory condition affecting the episclera, a thin layer of tissue covering the sclera (the white part of the eye), caused by Mycobacterium tuberculosis. This condition is often associated with systemic tuberculosis and can manifest as a localized or diffuse inflammation. Patients may present with symptoms such as redness, discomfort, and visual disturbances. Diagnosis typically involves a thorough clinical examination, including slit-lamp examination, and may be supported by imaging studies or laboratory tests to confirm the presence of tuberculosis. Treatment generally includes antitubercular therapy, which may involve a combination of isoniazid, rifampicin, ethambutol, and pyrazinamide, depending on the severity and extent of the disease. Monitoring for drug resistance is crucial, as multidrug-resistant tuberculosis (MDR-TB) can complicate treatment. Public health implications are significant, as tuberculous episcleritis may indicate active pulmonary or extrapulmonary tuberculosis, necessitating contact tracing and isolation procedures to prevent transmission. Regular follow-up is essential to assess treatment efficacy and manage any potential complications.
Detailed clinical notes including symptoms, examination findings, and diagnostic tests.
Patients presenting with ocular symptoms and a history of tuberculosis.
Need for collaboration with infectious disease specialists for comprehensive management.
Thorough documentation of tuberculosis diagnosis, treatment plans, and follow-up care.
Patients with systemic tuberculosis presenting with ocular manifestations.
Monitoring for drug resistance and public health reporting requirements.
Used for initial evaluation of a patient presenting with ocular symptoms.
Comprehensive examination notes and history of tuberculosis.
Ophthalmologists should document any systemic conditions affecting ocular health.
Common symptoms include redness of the eye, discomfort, and potential visual disturbances. Patients may also have a history of systemic tuberculosis.
Diagnosis is made through clinical examination, imaging studies, and laboratory tests to confirm the presence of tuberculosis.
Treatment typically involves antitubercular therapy, which may include a combination of isoniazid, rifampicin, ethambutol, and pyrazinamide, depending on the patient's condition.
